Abstract
Lynch syndrome (LS) is an autosomal dominant condition that predisposes to colorectal cancer and specific other tumors. Extracolonic tumors occur mainly in the endometrium, stomach, ovary, small intestine and urinary tract. The presence of rare tumors in patients belonging to families who have Lynch syndrome is always interesting, because the question arises whether these tumors should be considered as a coincidence or are related with the syndrome. In this last case, they are also the result of the defect in the mismatch repair system, opening the possibility of extending the tumor spectrum associated with the syndrome. Here we describe a patient from a Lynch syndrome family with a germline mutation c.2063T>G (p.M688R) in the MSH2 gene, who developed an adrenal cortical carcinoma, a tumor not usually associated with LS. We analyzed the adrenocortical tumour for microsatellite instability (MSI), LOH and the presence of the germline c.2063T>G (M688R) mutation. The adrenal cortical carcinoma showed the MSH2 mutation, loss of heterozygosity of the normal allele in the MSH2 gene and loss of immunohistochemical expression for MSH2 protein, but no microsatellite instability. Additionally, the adrenal cortical carcinoma did not harbour a TP53 mutation. The molecular study indicates that this adrenal cortical cancer is probably due to the mismatch repair defect.
Similar content being viewed by others
Abbreviations
- CRC:
-
Colorectal cancer.
- LOH:
-
Loss of heterozygosity.
- MMR:
-
Mismatch-repair.
- MRI:
-
Magnetic resonance imaging.
- MSI:
-
Microsatellite instability.
- PCR:
-
Polymerase chain reaction.
- PET:
-
Positron emissiont tomography.
- RFLP:
-
Restriction fragment length polymorphism.
- SSCP:
-
Single strand conformation polymorphism.
References
Lynch HT, de la Chapelle A (2003) Genomic medicine: hereditary colon cancer. N Engl J Med 348:919–932
Lynch HT, Lynch J (2000) Lynch syndrome: genetics, natural history, genetic counseling, and prevention. J Clin Oncol 18:19S–31S
Hampel H, Stephens J, Pukkala E et al (2005) Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 129:415–421
Watson P, Vasen HFA, Mecklin JP et al (2008) The risk of extra-colonic, extraendometrial cancer in the Lynch syndrome. Int J Cancer 123:444–449
Watson P, Lynch HT (1993) Extracolonic cancer in hereditary non-polyposis colorectal cancer. Cancer 71:677–685
Lynch HT, Lynch J (2000). Lynch syndrome: Genetics natural history, genetics counseling and Prevention. J Clin Oncol 18(21s):19s–31s
van der Post RS, Kiemeney LA, Ligtenberg MLJ et al (2010) Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. J Med Genet 47:464–470
Walsh MD, Buchanan DD, Cummings MC et al (2010) Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res 16(7):2214–2224
Sijmons R, Ilofstra R, IIollerna I et al (2000) Inclusion of malignant fibrous histiocytoma un the tumour spectrum associated with hereditary non-poliposis colorectal cancer. Genes Chromosom Cancer 29:353–355
Medina-Arana V, Barrios del Pino Y, García-Castro C et al (2002) Highly aggressive leiomyosarcoma associated with Lynch II syndrome: increasing the range of extracolonic cancers related with hereditary non-poliposis cancer. Ann Oncol 13:807–808
Medina-Arana V, Barrios Y, Fernández-Peralta A et al (2006) New founding mutation in HMSH2 associated with hereditary non-polyposis colorectal cancer syndrome on the island of Tenerife. Cancer Lett 244:268–273
Vasen HFA, Mecklin JP, Meera-Khan P, Lynch HT (1991) The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34:424–425
Vasen HFA, Watson MecklinJP, Lynch HT, The ICG-HNPCC (1999) New Clinical Criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch Syndrome). Proposed by the International collaborative group on HNPCC. Gastroenterology 116:145–1456
Boland CR, Thibodeau SN, Hamilton SR et al (1998) A National Cancer Institute workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257
Berends MJW, Cats A, IIollerna IL et al (2000) Adrenocortical adenocarcinoma in an MSH2 carrier: coincidence or causal relation? Human Pathol 31:1522–1527
Broaddus R, Lynch P, Lu K et al (2004) Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome. Mod Pathol 17:981–989
Medina-Arana V, Barrios del Pino I, González-Aguilera JJ et al (2004) Tumour spectrum of non-polyposis colorectal cancer (Lynch syndrome) on the island of Tenerife and influence of insularity on the clinical manifestations. Eur J Cancer Prev 13:27–32
Gorbalenya AE, Koonin EV (1990) Superfamily of UvrA-related NTP-binding proteins implication for rational classfication of recombination/repair systems. J Mol Biol 213:583–591
Hung LW, Wang IX, Nikaido K et al (1998) Crystal structure of the ATP-binding subunit of an ABC transporter. Nature 396:703–707
Wu TH, Marinus MG (1994) Dominant negative mutator mutations in the mutS gene of Escherichia coli. J Bacteriol 176:5393–5400
Drotschmann K, Clark AB, Tran HT et al (1999) Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene. Proc Natl Acad Sci USA 96:2970–2975
Studamire B, Quach T, Alani E (1998) Saccharomyces cerevisiae Msh2p and Msh6p ATPase activities are both required during mismatch repair. Mol Cell Biol 18:7590–7601
Obmolova G, Ban C, Hsieh P et al (2000) Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA. Nature 407:703–710
González-Aguilera JJ, Nejda N, Fernández FJ et al (2003) Genetic alterations and MSI status in primary, synchronous, and metachronous tumors in a family with hereditary non polyposis colorectal cancer (HNPCC). Am J Clin Oncol 26:386–391
Gomes-Pereira M, Fortune MT, Monckton DG et al (2001) Mouse tissue culture models of unstable triplet repeats: in vitro selection for larger alleles, mutational expansion bias and tissue specificity, but no association with cell division rates. Hum Mol Genet 10:845–854
Thornton CA, Johnson KJ, Moxley RT (1994) Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol 35:104–107
Acknowledgments
This work was supported by grant from the Fondo de Investigación Sanitaria FIS (04/0236).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Medina-Arana, V., Delgado, L., González, L. et al. Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome. Familial Cancer 10, 265–271 (2011). https://doi.org/10.1007/s10689-010-9416-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-010-9416-8